bongoboy

Tiny Accentia Biopharmaceuticals May Be On Its Way To Big Things

It has been a slow Phase three. But as you know this is not uncommon. I found this off the internet. Yes it is fro m january 2007. But I like who it came from. www.thomsonpharma.com/... They talk about the opportunity. And by the way I think Revimmune and Biovaxid really bring the risk down. Remember it only has a 56 million mkt cap. Look at all the one drug companies who have gotton "no's" fro the fda and somehow maintain 200 to 300 million mkt caps. I have to believe at these prices risk/reward is in my favor. Imagine if they did get their products approved? $30 or $40 Dollars? Who knows, but I like what i see!